Skip to main content
CHI Learning & Development System (CHILD)
Projects

Association Between Long Term Use of Sodium-glucose Co-transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal study

Project Categories

Applied/Translational Research

Care Continuum

Platform

National Healthcare Innovation and Productivity Medals

Cluster

National Healthcare Group

31 December 2021

Explore the longitudinal association between sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and cognitive function. Findings reveal potential neuro-protective benefits of SGLT2i, paving the way for future studies on cognitive decline in T2DM.

About this Content

Aims

Background

Methods

Results

Conclusion

Lessons Learnt

Additional Information

Keywords


Innovators' Details

Connect with this contributor!

Project Attachment

Back to top